Live Breaking News & Updates on Mount Sinai Innovation

Stay updated with breaking news from Mount sinai innovation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New study suggests that SARS-CoV-2 might indu

COVID-19, the disease resulting from SARS-CoV-2 infection, is associated with highly variable clinical outcomes that range from asymptomatic disease to death. For those with milder infections, COVID-19 can produce respiratory infection symptoms (cough, congestion, fever) and sensory phenotypes such as headache and loss of sense of smell. In more severe cases, SARS-CoV-2 infection can affect nearly every organ and result in strokes from vascular occlusion, cardiovascular damage and acute renal failure. A substantial number of actively infected patients suffering from both mild and severe infections experience sensory-related symptoms, such as headache, visceral pain, Guillain-Barre syndrome, nerve pain and inflammation. In most patients these symptoms subside after the infection ends, but, for other patients, they can persist.

In a new study, researchers from Boston University Chobanian & Avedisian School of Medicine, Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai ....

United States , Venetia Zachariou , Method Of Research , Boston University Chobanian Avedisian School Of Medicine , Zegar Family Foundation , Bu Chobanian Avedisian School Of Medicine , York University , National Institute Of Neurological Disorders , Friedman Brain Institute Research Scholars Program , Boston University Chobanian , Avedisian School , Icahn School , Mount Sinai , Icahn Mount Sinai , New York University , Post Covid Conditions , Long Covid , Icahn Mount , National Institute , Neurological Disorders , Mount Sinai Innovation , Sinai Innovation Partners , Mount Sinai Innovation Partners ,